uniQure
QURE
$4.67
Share price
-0.85%
Change (1 day)
-76.12%
Change (1 year)
uniQure (QURE) - Total debt
Total debt on the balance sheet as of December 2023 : $0.13 B
According to uniQure's latest financial reports the company's total debt is $0.13 B. A company’s total debt is the sum of all current and non-current debts.
uniQure - Total debt on balance sheet (from 2012 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.13 B | -3.14% |
| 2022-12-31 | $0.14 B | 5.28% |
| 2021-12-31 | $0.13 B | 89.71% |
| 2020-12-31 | $71.54 M | -2.08% |
| 2019-12-31 | $73.06 M | 105.97% |
| 2018-12-31 | $35.47 M | 70.61% |
| 2017-12-31 | $20.79 M | 2.74% |
| 2016-12-31 | $20.23 M | 0.13% |
| 2015-12-31 | $20.21 M | -3.56% |
| 2014-12-31 | $20.95 M | 103.88% |
| 2013-12-31 | $10.27 M | 1627.23% |
| 2012-12-31 | $0.59 M | 155.09% |
| 2011-12-31 | $0.23 M | -20.63% |
| 2010-12-31 | $0.29 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $64.61 B | 46,582.66% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | 14,615.16% | 🇫🇷 France |
 Sangamo Therapeutics
SGMO | $38.1 M | -72.47% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.30 B | 119.43% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.09 B | 691.68% | 🇺🇸 USA |
 Avidity Biosciences RNA | $9.85 M | -92.88% | 🇺🇸 USA |